<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Recash test site | Santos Eskesen | Activity</title>
	<link>https://recash.wpsoul.net/members/teethoffer96/activity/</link>
	<atom:link href="https://recash.wpsoul.net/members/teethoffer96/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Santos Eskesen.</description>
	<lastBuildDate>Wed, 29 Jul 2026 09:19:54 +0000</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">ba0c8d69bedc04ea64d9a31617b26347</guid>
				<title>Santos Eskesen posted an update: There is a statistically significant association between [&#133;]</title>
				<link>https://recash.wpsoul.net/activity/p/141873/</link>
				<pubDate>Sat, 04 Jan 2025 08:07:09 +0000</pubDate>

									<content:encoded><![CDATA[<p>There is a statistically significant association between M235T-AGT and CA, when adjusting for several confounders and controlling for hypertension.</p>
<p> We compared the adequacy of five nutrition assessment tools with respect to their predictive value in patients with locally advanced gastric cancer (GC) receiving radical surgery.</p>
<p> Five&hellip;<span class="activity-read-more" id="activity-read-more-141873"><a href="https://recash.wpsoul.net/activity/p/141873/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">321a7ccf7458e0766d550dd786ef698d</guid>
				<title>Santos Eskesen posted an update: In phase 2, the median progression-free survival was 4.7 (95% [&#133;]</title>
				<link>https://recash.wpsoul.net/activity/p/136024/</link>
				<pubDate>Thu, 02 Jan 2025 08:07:32 +0000</pubDate>

									<content:encoded><![CDATA[<p>In phase 2, the median progression-free survival was 4.7 (95% confidence interval, 3.75 to not reached) months. Median overall survival was not reached. Isatuximab monotherapy was well tolerated and effective in patients with heavily pretreated RRMM including high-risk cytogenetic patients. This trial is registered at ClinicalTrials.gov as&hellip;<span class="activity-read-more" id="activity-read-more-136024"><a href="https://recash.wpsoul.net/activity/p/136024/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">3bb57601843624c1de5bf427fa652a4f</guid>
				<title>Santos Eskesen posted an update: Statistical analysis was performed using one-way ANOVA and [&#133;]</title>
				<link>https://recash.wpsoul.net/activity/p/133207/</link>
				<pubDate>Wed, 01 Jan 2025 08:08:45 +0000</pubDate>

									<content:encoded><![CDATA[<p>Statistical analysis was performed using one-way ANOVA and shows significant differences between the obtained results.Polydopamine has been widely used as an additive to enhance membrane fouling resistance. This study reports the effects of two-step dopamine-to-polydopamine modification on the permeation, antifouling, and potential anti-UV&hellip;<span class="activity-read-more" id="activity-read-more-133207"><a href="https://recash.wpsoul.net/activity/p/133207/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">ff2add9991de42c5c25ab899ab06177c</guid>
				<title>Santos Eskesen posted an update: KO mice lacked epileptic seizures when fed a low lysine/high [&#133;]</title>
				<link>https://recash.wpsoul.net/activity/p/127193/</link>
				<pubDate>Mon, 30 Dec 2024 08:06:45 +0000</pubDate>

									<content:encoded><![CDATA[<p>KO mice lacked epileptic seizures when fed a low lysine/high PN diet. Switching mice to a high lysine/low PN diet led to vigorous seizures and a quick death in KO mice. <a href="https://www.selleckchem.com/products/Temsirolimus.html" rel="nofollow ugc">mTOR inhibitor</a> Treatment with PN controlled seizures and improved survival of high-lysine/low PN fed KO mice. This study expands the spectrum of biochemical abnormalities that may&hellip;<span class="activity-read-more" id="activity-read-more-127193"><a href="https://recash.wpsoul.net/activity/p/127193/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">5fa94e2b35bdb6b007c88c0eafcc2f07</guid>
				<title>Santos Eskesen posted an update: Utilizing quantum effects in complex oxides, such as [&#133;]</title>
				<link>https://recash.wpsoul.net/activity/p/124290/</link>
				<pubDate>Sun, 29 Dec 2024 08:10:52 +0000</pubDate>

									<content:encoded><![CDATA[<p>Utilizing quantum effects in complex oxides, such as magnetism, multiferroicity and superconductivity, requires atomic-level control of the material&#8217;s structure and composition. <a href="https://www.selleckchem.com/products/glafenine.html" rel="nofollow ugc">Glafenine order</a> In contrast, the continuous conductivity changes that enable artificial oxide-based synapses and multiconfigurational devices are driven by redox reactions&hellip;<span class="activity-read-more" id="activity-read-more-124290"><a href="https://recash.wpsoul.net/activity/p/124290/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">3b415027cec932385e1d6f1f85c5fd89</guid>
				<title>Santos Eskesen became a registered member</title>
				<link>https://recash.wpsoul.net/activity/p/94924/</link>
				<pubDate>Fri, 20 Dec 2024 17:17:31 +0000</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>